Premium Article
The hidden cost of getting treatment decisions wrong Colorectal cancer (CRC) is one of the most prevalent and lethal cancers worldwide, ranking among the ...
April 02, 2026 | Expert Insight | By Dr. Torbjørn Furuseth, CEO and Co-Founder, DoMore Diagnostics
Gibco CHOvantage GS Cell Line Development Kit delivers high productivity, streamlined timelines and royalty-free, clinical-stage licensing options to suppo...
April 02, 2026 | News
APAC Biopharma in Review: What Truly Moved the Needle This Year Asia-Pacific (APAC) has cemented its status as a pivotal biopharmaceutical hub in 2025, ma...
December 15, 2025 | Report
Takeda Pharmaceutical, one of the world’s most globalised pharma companies, has confirmed it will step away from in-house development of its cell and...
October 05, 2025 | News
India’s Diabetes Burden and Global Stakes: India is often called the “diabetes capital of the world,” and not without reason. Recent esti...
September 24, 2025 | Analysis | By editor@biopharmaapac.com
According to the Centers for Disease Control and Prevention (CDC), over 38 million Americans have diabetes. Of these, around 90% to 95% have Type 2 diabete...
September 18, 2025 | News
In 2025, Asia-Pacific has emerged as the fastest-growing hub for biotech and life sciences employment, fuelled by a powerful combination of government supp...
September 09, 2025 | Report
The Phase I/II CLINCH study of ATG-022 (CLDN18.2 antibody-drug conjugate) demonstrated promising results, showing robust clinical efficacy and a fav...
August 25, 2025 | Company results
The first seven months of 2025 saw robust dealmaking in China’s biopharma and healthcare sector, even as global headwinds tempered some activity. Chi...
August 15, 2025 | Report
The future of medicine is being shaped at the intersection of spatial biology and artificial intelligence—and 10x Genomics is l...
August 07, 2025 | Interaction
Sarthak Ranade, Area Managing Director of Johnson & Johnson Innovative Medicine for SEA and India, believes the era of precision medicine is no longer ...
July 23, 2025 | Opinion | By Sarthak Ranade, Area Managing Director, J&J Innovative Medicine, SEA & India
As we cross the midpoint of 2025, BioPharma APAC presents this Mid-Year Report—an incisive look at emerging biopharmaceutical dynamics, key i...
July 21, 2025 | Analysis
With up to 90% of new chemical entities suffering from poor water solubility, pharmaceutical innovators are under pressure to reformulate for eff...
July 09, 2025 | Interview
This cloud-native, SaaS-based platform breaks down traditional barriers in drug discovery by uniting all disciplines—biology, chemistry, and computat...
July 07, 2025 | Opinion | By Saurabh Singal | CEO-Founder, Molecule AI
Most Read
Bio Jobs
News